Genomic analysis of SARS-CoV-2 variants: diagnosis and vaccination challenges

References

• Abbasi, H., Nikoo, H. R., Fallah, A., Mohammad-Hasani, A., Colagar, A. H., & Khosravi, A. (2022). The features of pathobiology and clinical translation of approved treatments for coronavirus disease 2019 (COVID-19). Intervirology, 65(3), 119–133. https://doi.org/10.1159/000520234
   PubMed Web of Science ®Google Scholar
• Abbasi, H., Tabaraei, A., Hosseini, S. M., Khosravi, A., & Nikoo, H. R. (2022). Real-time PCR Ct value in SARS-CoV-2 detection: RdRp or N gene? Infection, 50(2), 537–540. https://doi.org/10.1007/s15010-021-01674-x
   PubMed Web of Science ®Google Scholar
• Aleem, A., Ab, A. S., & Slenker, A. K. (2021). Emerging variants of SARS-CoV-2 and novel therapeutics against coronavirus (COVID-19). In StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. PMID: 34033342.
   Google Scholar
• Boehm, E., Kronig, I., Neher, R. A., Eckerle, I., Vetter, P., & Kaiser, L., Geneva Centre for Emerging Viral Diseases. (2021). Novel SARS-CoV-2 variants: The pandemics within the pandemic. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 27(8), 1109–1117. https://doi.org/10.1016/j.cmi.2021.05.022
   PubMed Web of Science ®Google Scholar
• Burke, M. J., Scott, J. N., Minshull, T. C., Gao, Z., Manfield, I., Savic, S., Stockley, P. G., Calabrese, A. N., & Boyes, J. (2022). A bovine antibody possessing an ultralong complementarity-determining region CDRH3 targets a highly conserved epitope in sarbecovirus spike proteins. The Journal of Biological Chemistry, 298(12), 102624. https://doi.org/10.1016/j.jbc.2022.102624
   PubMed Web of Science ®Google Scholar
• Cascella, M., Rajnik, M., Aleem, A., Dulebohn, S. C., & Di Napoli, R. (2022). Features, evaluation, and treatment of coronavirus (COVID-19). In StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. PMID: 32150360.
   Google Scholar
• Choi, J. Y., & Smith, D. M. (2021). SARS-CoV-2 variants of concern. Yonsei Medical Journal, 62(11), 961–968. https://doi.org/10.3349/ymj.2021.62.11.961
   PubMed Web of Science ®Google Scholar
• Dai, L., & Gao, G. F. (2021). Viral targets for vaccines against COVID-19. Nature Reviews. Immunology, 21(2), 73–82. https://doi.org/10.1038/s41577-020-00480-0
   PubMed Web of Science ®Google Scholar
• Durand, M., Thibault, P., Lévesque, S., Brault, A., Carignan, A., Valiquette, L., Martin, P., & Labbé, S. (2022). Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its first variants in fourplex real-time quantitative reverse transcription-PCR assays. Microbial Cell (Graz, Austria), 9(1), 1–20. https://doi.org/10.15698/mic2022.01.767
   PubMed Web of Science ®Google Scholar
• Edara, V. V., Hudson, W. H., Xie, X., Ahmed, R., & Suthar, M. S. (2021). Neutralizing antibodies against SARS-CoV-2 variants after infection and vaccination. JAMA, 325(18), 1896–1898. https://doi.org/10.1001/jama.2021.4388
   PubMed Web of Science ®Google Scholar
• Flores-Vega, V. R., Monroy-Molina, J. V., Jiménez-Hernández, L. E., Torres, A. G., Santos-Preciado, J. I., & Rosales-Reyes, R. (2022). SARS-CoV-2: Evolution and emergence of new viral variants. Viruses, 14(4), 653. https://doi.org/10.3390/v14040653
   PubMed Web of Science ®Google Scholar
• Gand, M., Vanneste, K., Thomas, I., Van Gucht, S., Capron, A., Herman, P., Roosens, N. H., & De Keersmaecker, S. C. (2021). Deepening of in silico evaluation of SARS-CoV-2 detection RT-qPCR assays in the context of new variants. Genes, 12(4), 565. https://doi.org/10.3390/genes12040565
   PubMed Web of Science ®Google Scholar
• Harvey, W. T., Carabelli, A. M., Jackson, B., Gupta, R. K., Thomson, E. C., Harrison, E. M., Ludden, C., Reeve, R., Rambaut, A., Peacock, S. J., & Robertson, D. L., COVID-19 Genomics UK (COG-UK) Consortium. (2021). SARS-CoV-2 variants, spike mutations and immune escape. Nature Reviews. Microbiology, 19(7), 409–424. https://doi.org/10.1038/s41579-021-00573-0
   PubMed Web of Science ®Google Scholar
• Huang, Y., Yang, C., Xu, X.-f., Xu, W., & Liu, S.-w. (2020). Structural and functional properties of SARS-CoV-2 spike protein: Potential antivirus drug development for COVID-19. Acta Pharmacologica Sinica, 41(9), 1141–1149. https://doi.org/10.1038/s41401-020-0485-4
   PubMed Web of Science ®Google Scholar
• Jangra, S., Ye, C., Rathnasinghe, R., Stadlbauer, D., Krammer, F., Simon, V., Martinez-Sobrido, L., Garcia-Sastre, A., & Schotsaert, M., P. S. Group. (2021). The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera. MedRxiv.
   Google Scholar
• Kevadiya, B. D., Machhi, J., Herskovitz, J., Oleynikov, M. D., Blomberg, W. R., Bajwa, N., Soni, D., Das, S., Hasan, M., Patel, M., Senan, A. M., Gorantla, S., McMillan, J., Edagwa, B., Eisenberg, R., Gurumurthy, C. B., Reid, S. P. M., Punyadeera, C., Chang, L., & Gendelman, H. E. (2021). Diagnostics for SARS-CoV-2 infections. Nature Materials, 20(5), 593–605. https://doi.org/10.1038/s41563-020-00906-z
   PubMed Web of Science ®Google Scholar
• Kumar, S., Stecher, G., Li, M., Knyaz, C., & Tamura, K. (2018). MEGA X: Molecular evolutionary genetics analysis across computing platforms. Molecular Biology and Evolution, 35(6), 1547–1549. https://doi.org/10.1093/molbev/msy096
   PubMed Web of Science ®Google Scholar
• Kyriakidis, N. C., López-Cortés, A., González, E. V., Grimaldos, A. B., & Prado, E. O. (2021). SARS-CoV-2 vaccines strategies: A comprehensive review of phase 3 candidates. NPJ Vaccines, 6(1), 28. https://doi.org/10.1038/s41541-021-00292-w
   PubMed Web of Science ®Google Scholar
• Larsson, A. (2014). AliView: A fast and lightweight alignment viewer and editor for large datasets. Bioinformatics (Oxford, England), 30(22), 3276–3278. https://doi.org/10.1093/bioinformatics/btu531
   PubMed Web of Science ®Google Scholar
• Lesbon, J. C. C., Poleti, M. D., de Mattos Oliveira, E. C., Patané, J. S. L., Clemente, L. G., Viala, V. L., Ribeiro, G., Giovanetti, M., de Alcantara, L. C. J., Teixeira, O., Nonato, M. C., de Lima, L. P. O., Martins, A. J., Dos Santos Barros, C. R., Marqueze, E. C., de Souza Todão Bernardino, J., Moretti, D. B., Brassaloti, R. A., de Lello Rocha Campos Cassano, R., … Fukumasu, H. (2021). Nucleocapsid (N) gene mutations of SARS-CoV-2 can affect real-time RT-PCR diagnostic and impact false-negative results. Viruses, 13(12), 2474. https://doi.org/10.3390/v13122474
   PubMed Web of Science ®Google Scholar
• Li, T., Xue, W., Zheng, Q., Song, S., Yang, C., Xiong, H., Zhang, S., Hong, M., Zhang, Y., Yu, H., Zhang, Y., Sun, H., Huang, Y., Deng, T., Chi, X., Li, J., Wang, S., Zhou, L., Chen, T., … Xia, N. (2021). Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants. Nature Communications, 12(1), 5652. https://doi.org/10.1038/s41467-021-25997-3
   PubMed Web of Science ®Google Scholar
• Liu, L., Chen, T., Zhou, L., Sun, J., Li, Y., Nie, M., Xiong, H., Zhu, Y., Xue, W., Wu, Y., Li, T., Zhang, T., Kong, Z., Yu, H., Zhang, J., Gu, Y., Zheng, Q., Zhao, Q., Xia, N., & Li, S. (2022). A bacterially expressed SARS-CoV-2 receptor binding domain fused with cross-reacting material 197 A-domain elicits high level of neutralizing antibodies in mice. Frontiers in Microbiology, 13, 854630–854630. https://doi.org/10.3389/fmicb.2022.854630
   PubMed Web of Science ®Google Scholar
• Mittal, A., Khattri, A., & Verma, V. (2022). Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants. PLoS Pathogens, 18(2), e1010260. https://doi.org/10.1371/journal.ppat.1010260
   PubMed Web of Science ®Google Scholar
• Nakabayashi, T., Kawasaki, Y., Murashima, K., Omi, K., & Yuhara, S. (2021). Evaluation of the effects of SARS-CoV-2 genetic mutations on diagnostic RT-PCR assays. bioRxiv.
   Google Scholar
• Otto, S. P., Day, T., Arino, J., Colijn, C., Dushoff, J., Li, M., Mechai, S., Van Domselaar, G., Wu, J., Earn, D. J. D., & Ogden, N. H. (2021). The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic. Current Biology: CB, 31(14), R918–R929. https://doi.org/10.1016/j.cub.2021.06.049
   PubMed Web of Science ®Google Scholar
• Pal, M., Berhanu, G., Desalegn, C., & Kandi, V. (2020). Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): An update. Cureus, 12(3), e7423. https://doi.org/10.7759/cureus.7423
   PubMed Web of Science ®Google Scholar
• Parra-Lucares, A., Segura, P., Rojas, V., Pumarino, C., Saint-Pierre, G., & Toro, L. (2022). Emergence of SARS-CoV-2 variants in the world: How could this happen? Life, 12(2), 194. https://doi.org/10.3390/life12020194
   PubMedGoogle Scholar
• Peisahovics, F., Rohaim, M. A., & Munir, M. (2022). Structural topological analysis of spike proteins of SARS-CoV-2 variants of concern highlight distinctive amino acid substitution patterns. European Journal of Cell Biology, 101(4), 151275. https://doi.org/10.1016/j.ejcb.2022.151275
   PubMed Web of Science ®Google Scholar
• Rahimi, A., Mirzazadeh, A., & Tavakolpour, S. (2021). Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection. Genomics, 113(1 Pt 2), 1221–1232. https://doi.org/10.1016/j.ygeno.2020.09.059
   PubMed Web of Science ®Google Scholar
• Tao, K., Tzou, P. L., Nouhin, J., Gupta, R. K., de Oliveira, T., Kosakovsky Pond, S. L., Fera, D., & Shafer, R. W. (2021). The biological and clinical significance of emerging SARS-CoV-2 variants. Nature Reviews. Genetics, 22(12), 757–773. https://doi.org/10.1038/s41576-021-00408-x
   PubMed Web of Science ®Google Scholar
• Thye, A. Y.-K., Law, J. W.-F., Pusparajah, P., Letchumanan, V., Chan, K.-G., & Lee, L.-H. (2021). Emerging SARS-CoV-2 variants of concern (VOCs): An impending global crisis. Biomedicines, 9(10), 1303. https://doi.org/10.3390/biomedicines9101303
   PubMed Web of Science ®Google Scholar
• Tombuloglu, H., Sabit, H., Al-Khallaf, H., Kabanja, J. H., Alsaeed, M., Al-Saleh, N., & Al-Suhaimi, E. (2022). Multiplex real-time RT-PCR method for the diagnosis of SARS-CoV-2 by targeting viral N, RdRP and human RP genes. Scientific Reports, 12(1), 2853. https://doi.org/10.1038/s41598-022-06977-z
   PubMed Web of Science ®Google Scholar
• Vega-Magaña, N., Sánchez-Sánchez, R., Hernández-Bello, J., Venancio-Landeros, A. A., Peña-Rodríguez, M., Vega-Zepeda, R. A., Galindo-Ornelas, B., Díaz-Sánchez, M., García-Chagollán, M., Macedo-Ojeda, G., García-González, O. P., & Muñoz-Valle, J. F. (2021). RT-qPCR assays for rapid detection of the N501Y, 69-70del, K417N, and E484K SARS-CoV-2 mutations: a screening strategy to identify variants with clinical impact. Frontiers in Cellular and Infection Microbiology, 11, 672562. https://doi.org/10.3389/fcimb.2021.672562
   PubMed Web of Science ®Google Scholar
• Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C., Muecksch, F., Rutkowska, M., Hoffmann, H.-H., Michailidis, E., Gaebler, C., Agudelo, M., Cho, A., Wang, Z., Gazumyan, A., Cipolla, M., Luchsinger, L., Hillyer, C. D., Caskey, M., … Bieniasz, P. D. (2020). Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. eLife, 9, e61312. https://doi.org/10.7554/eLife.61312
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2020). Summary table of available protocols in this document. Who In House Assays. In: Overview. https://www. who. int/docs/default-source/coronaviruse/whoinhouseassays.pdf.
   Google Scholar
• Yang, J., Wang, W., Chen, Z., Lu, S., Yang, F., Bi, Z., Bao, L., Mo, F., Li, X., Huang, Y., Hong, W., Yang, Y., Zhao, Y., Ye, F., Lin, S., Deng, W., Chen, H., Lei, H., Zhang, Z., … Wei, X. (2020). A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature, 586(7830), 572–577. https://doi.org/10.1038/s41586-020-2599-8
   PubMed Web of Science ®Google Scholar
• Zhang, L., Jackson, C. B., Mou, H., Ojha, A., Peng, H., Quinlan, B. D., Rangarajan, E. S., Pan, A., Vanderheiden, A., Suthar, M. S., Li, W., Izard, T., Rader, C., Farzan, M., & Choe, H. (2020). SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity. Nature Communications, 11(1), 6013. https://doi.org/10.1038/s41467-020-19808-4
   PubMed Web of Science ®Google Scholar
• Zimmermann, F., Urban, M., Krüger, C., Walter, M., Wölfel, R., & Zwirglmaier, K. (2022). In vitro evaluation of the effect of mutations in primer binding sites on detection of SARS-CoV-2 by RT-qPCR. Journal of Virological Methods, 299, 114352. https://doi.org/10.1016/j.jviromet.2021.114352
   PubMed Web of Science ®Google Scholar